Skip to content

Net margin at other companies

Eli Lilly logo
Eli LillyLLY
35%+12.3pp
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
-166.4%-195pp
Immunome logo
ImmunomeIMNM
-5,593.8%-11,284pp
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-508.5%-254pp
Lantheus Holdings logo
Lantheus HoldingsLNTH
18%+0.7pp
uniQure logo
uniQureQURE
-1,154.4%+89.3pp

Other financials

Income statement

See full
Revenue$2.2M+27.3%
Gross profit$738.0K+78.3%
Operating income-$28.3M-29.5%
Net income-$26.2M-44.1%
EPS (diluted)-$0.250.0%

Balance sheet

See full
Cash & equivalents$54.0M+21.5%
Total debt$4.2M+10.9%
Total equity$347.4M+22.1%
Total assets$410.8M+24.7%

Cash flow

See full
Operating cash flow-$31.5M-45.8%
CapEx$6.9M+47.3%
Free cash flow-$38.3M-46.1%

Valuation

See full
Market cap$342.14M+33.2%
Enterprise value$292.34M+35.2%
P/S34.2×+19.6×

Profitability

See full
Gross margin33.1%-7.1pp
Operating margin-292.7%-553pp
FCF margin-1,073.3%

Returns & leverage

See full
Return on equity-35.2%+2.3pp
Debt / equity0.0×
Current ratio8.7×-8.3×

Where this comes from

Calculated from Perspective Therapeutics’s reported figures.

Based on trailing twelve months.

The official record: Perspective Therapeutics’s 10-Q, filed November 12, 2024, on SEC EDGAR. View the filing →

Ask your AI about Perspective Therapeutics's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Perspective Therapeutics's net margin?
Perspective Therapeutics (CATX) reported net margin of -218.4% in Q3 2023.
How has Perspective Therapeutics's net margin changed year-over-year?
Perspective Therapeutics's net margin decreased by 138.8% year-over-year, from -91.4% to -218.4%.
What is the long-term trend for Perspective Therapeutics's net margin?
Over 2 years (2020 to 2022), Perspective Therapeutics's net margin has grown at a 42.4% compound annual growth rate (CAGR), from -34.2% to -69.4%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.